News & Updates
Media Inquiries
If you’re a member of the media and looking to speak with an expert at Reproductive Equity Now, contact our press team at press@reproequitynow.org!
If you have a general question or comment, please email info@reproequitynow.org.
Reproductive Equity Now Responds After Supreme Court Extends Temporary Stay, Allowing Telehealth Access to Mifepristone Until Thursday
Today, the United States Supreme Court extended the temporary administrative stay that restored access to mifepristone, the first drug used in a common two-drug medication abortion regimen, via the mail until at least Thursday, May 14, 2026.
Connecticut Leaders Call for Urgent Action to Protect Telehealth Abortion Access Amid Ongoing Court Chaos
Today, Connecticut leaders, including Connecticut’s Governor Ned Lamont and Attorney General William Tong, lawmakers, and advocates called for urgent state action to protect telehealth abortion access following rapidly shifting federal court rulings in Louisiana et al. v. Food and Drug Administration. Watch the full press conference HERE.
Reproductive Equity Now Statement After Supreme Court Temporarily Restores Telehealth Mifepristone Access
Today, the United States Supreme Court issued an ordertemporarily restoring access to mifepristone, the first drug used in a common two-drug medication abortion regimen, via the mail and retail pharmacy. The order, issued by Justice Samuel Alito, the justice who manages emergency requests regarding the Fifth Circuit, imposes a temporary pause on a U.S. Court of Appeals for the Fifth Circuit ruling from Friday night that reinstated medically unnecessary restrictions on mifepristone, until at least May 11. Justice Alito ordered Louisiana to respond by Thursday at 5 p.m. From there, the full U.S. Supreme Court will determine how to proceed.
Reproductive Equity Now Decries the Biggest Blow to Abortion Access Since the Dobbs Decision
Reproductive Equity Now released a statement following the U.S. Court of Appeals for the Fifth Circuit decision’s ruling in Louisiana et al. v. Food and Drug Administration(FDA), which reimposes medically unnecessary in-person dispensing requirements on mifepristone, the first drug used in the common two-drug regimen for medication abortion.
Reproductive Equity Now Applauds Reproductive Health Equity Investments in Massachusetts House State Budget
Yesterday, the Massachusetts House of Representatives advanced its annual budget for Fiscal Year 2027. Included in the budget are several priorities championed by Reproductive Equity Now as part of the organization’s efforts to urge the legislature to invest in reproductive health care access for Bay Staters.
Advocates Call on Lawmakers to Deliver on Reproductive Health Before Session Ends
With only one week left in the legislative session, reproductive rights advocates, medical professionals, and community leaders gathered today at the Connecticut General Assembly to press lawmakers to act now and pass critical reproductive health legislation.
New Hampshire Senate Judiciary Committee to Hold Hearing on Shielding Anti-Abortion Centers from Oversight
Reproductive Equity Now’s New Hampshire State Director, Christina Warriner Hamilton, released the following statement in advance of a public hearing in the Senate Judiciary Committee on Shielding So-Called “Pregnancy Resource Centers” from Future Oversight (HB 1416), legislation that would bind future legislatures from regulating facilities that often promote anti-abortion disinformation.
Reproductive Equity Now Foundation Publishes Implementation Plan to Expand Contraceptive Access
Today, the Reproductive Equity Now Foundation published a new report titled Implementing Expansive Contraceptive Access: A Comprehensive Assessment and Strategic Action Plan for Connecticut, Massachusetts, and New Hampshire. This report is viewable both as a PDF document (available HERE) and via an interactive website (click HERE).
Medication Abortion Remains Available—But Under Increasing Threat
Taylor St. Germain, interim co-Executive Director with Reproductive Equity Now, released a statement following a federal district court's decision to place a hold on Louisiana v FDA, a case attempting to reinstate an in-person dispensing requirement for mifepristone nationwide.
Reproductive Equity Now Responds to HHS Attacks on Massachusetts Abortion Coverage Mandate
Reproductive Equity Now Interim Co-Executive Director Claire Teylouni released the following statement after the U.S. Department of Health and Human Services announced that it will investigate Massachusetts’ mandate that health insurance plans cover abortion care. The Trump administration is investigating 13 states, all of which protect abortion care, in an attempt to roll back reproductive freedom, especially for those who face the greatest barriers to care.
New Report Shows Number of Out-of-State Abortions from Massachusetts Providers Doubled from 2023 to 2024
Reproductive Equity Now released the following statement in response to the Massachusetts Department of Public Health’s release of the latest 2024 abortion data. This report shows a significant increase in the number of abortions provided to out-of-state patients, with 27, 836 individuals accessing care from Massachusetts providers — nearly double the number reported in 2023.
Proposed 20 Week Abortion Ban Defeated in New Hampshire
Today, Christina Warriner Hamilton, New Hampshire State Director for Reproductive Equity Now, released a statement after the New Hampshire House of Representatives abandoned a 20 Week Abortion Ban (HB 1590), legislation that would have further restricted abortion access in New Hampshire, by failing to advance it out of the New Hampshire House of Representatives.
Reproductive Equity Now Advocates for Equitable Coverage for Fertility Care, Contraception, and Gender-Affirming Care
Yesterday, Reproductive Equity Now’s Connecticut State Director, Liz Gustafson, testified in front of the Human Services Committee in support of both H.B. 5482, An Act Concerning Twelve Month Coverage for Contraception and Hormone Therapy, and H.B. 5483, An Act Concerning Fertility Care Under The Medicaid Program. These bills will increase access to the full spectrum of reproductive health care by ensuring that fertility care, a 12-month supply of hormonal birth control, and a 12-month supply of gender-affirming care are available to Connecticut residents enrolled in HUSKY, the state’s Medicaid program. Currently, the state mandates that only some private insurers cover these services.
New Hampshire House Set to Vote on Slate of Anti-Abortion Bills
Starting today, the New Hampshire House of Representatives is set to vote on a slate of anti-abortion bills. The House will meet in session today, Wednesday, March 11, at 9:00 a.m., and Thursday, March 12, at 9:00 a.m to vote on these bills. You can watch a livestream of the NH House Floor HERE.
Reproductive Equity Now Slams New Hampshire Senate Rejection of Shield Law
Despite strong support from constituents and providers in New Hampshire, today, the New Hampshire Senate voted on party lines to defeat the Shield Law for Reproductive Health Care Access (SB 551), legislation that would protect patients and providers in New Hampshire from out-of-state political interference, intimidation, and legal threats related to reproductive health care.
Reproductive Equity Now Testifies in Support of Bolstering Connecticut Shield Law
Yesterday, Reproductive Equity Now’s Connecticut State Director, Liz Gustafson, testified in front of the Connecticut Joint Judiciary Committee in support of Bolstering Shield Protections for Telehealth (S.B. 295), legislation to expand Connecticut’s shield law to protect abortion and gender-affirming care providers from hostile out-of-state prosecution when delivering care via telehealth, regardless of the patient’s location.
Reproductive Equity Now Testifies Against Restricting Minors’ Access to Abortion Care
Yesterday, Reproductive Equity Now’s Interim Co-Executive Director, Claire Teylouni, testified in front of the Connecticut Joint Judiciary Committee in opposition to Restricting Minors’ Access to Abortion Care (H.B. 5309), legislation that would limit young people’s autonomy and ability to access pregnancy-related care by requiring parental notification for abortion care.
Ahead of Judiciary Hearing, Reproductive Equity Now Calls on CT Lawmakers to Bolster Shield Law Protections
Connecticut State Director for Reproductive Equity Now, Liz Gustafson, released a statement ahead of today’s Judiciary Committee Public Hearing on S.B. 295, Bolstering Shield Protections for Interstate Telehealth, legislation that would bolster Connecticut’s provider shield law to ensure reproductive and gender-affirming health care providers are protected from hostile out-of-state prosecution when providing care via telehealth, regardless of a patient’s location.
Reproductive Equity Now, Advocates Testify Against 20-Week Abortion Ban Proposal
Today, Reproductive Equity Now’s Senior Director of Policy & Programs, Claire Teylouni, testified in front of the New Hampshire House Judiciary Committee in opposition to H.B. 1590, legislation that would establish a 20-week abortion ban in New Hampshire. After the Committee hearing, the Judiciary Committee entered into executive session during which they recommended the bill inexpedient to legislate (ITL), meaning they recommended that the bill not advance, on a 13-4 vote.
REN Slams 20-Week Abortion Ban as “Out-of-Touch” and a Broken Promise
Claire Teylouni, Senior Director for Policy and Programs at Reproductive Equity Now (REN), released the following statement ahead of the New Hampshire House Judiciary Committee's consideration of HB 1590, a bill introduced by Rep. Kevin Scully (R-Nashua) that would ban abortion at 20 weeks.